TYRONE BRININGER, PA
Physician Assistant · CLEVELAND, OH
Individual Active NPI 1689271090
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 282 | 190,422 | $16,182,702 | $7,251,653 | $5,768,715 |
| 2023 | 214 | 130,459 | $14,484,986 | $4,471,739 | $3,555,663 |
| 2022 | 125 | 39,045 | $5,830,059 | $2,054,942 | $1,637,630 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 41,100 | $21 | $16 |
| J1306 | Injection, inclisiran, 1 mg | 38,340 | $12 | $10 |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 22,890 | $18 | $14 |
| J2182 | Injection, mepolizumab, 1 mg | 11,200 | $30 | $24 |
| J3245 | Injection, tildrakizumab, 1 mg | 7,600 | $131 | $105 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 6,330 | $31 | $24 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 1,782 | $0 | $0 |
| J0517 | Injection, benralizumab, 1 mg | 1,320 | $154 | $122 |
| 96372 | Injection of drug or substance under skin or into muscle | 722 | $11 | $9 |
| J0897 | Injection, denosumab, 1 mg | 720 | $25 | $19 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 226 | $98 | $78 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 223 | $48 | $38 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Physician Assistant | 363A00000X | ✓ | 50.006711 | OH |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Physician Assistant providers in Ohio
- NPI 1710581061
- NPI 1558237909
- NPI 1043632599
- NPI 1295263267
- NPI 1922712702
- NPI 1154064830
- NPI 1689648099
- NPI 1134469547
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.